Related Experiment Video
Updated: Mar 13, 2026
08:14
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
16.3K
Obstacles to and Solutions for a Successful Lung Cancer Screening Program
1Department of Pulmonary Medicine, Cleveland Clinic, Respiratory Institute, Cleveland, Ohio.
Seminars in Respiratory and Critical Care Medicine
|October 13, 2016
Summary
Low-dose chest CT scans for lung cancer screening can reduce lung cancer deaths in high-risk individuals. Effective screening programs must address potential harms and obstacles for optimal benefit.
Area of Science:
- Pulmonology
- Radiology
- Public Health
Background:
- Lung cancer screening using low-dose computed tomography (LDCT) significantly reduces mortality in specific high-risk populations.
- Potential harms include psychological distress and medical complications from follow-up procedures for detected abnormalities.
Purpose of the Study:
- To review the evidence supporting the benefits and harms of lung cancer screening.
- To identify and discuss obstacles hindering the development of high-quality lung cancer screening programs.
Main Methods:
- Systematic review of existing evidence on lung cancer screening benefits and harms.
- Analysis of 11 key obstacles to successful screening program implementation.
Main Results:
- LDCT screening demonstrates a mortality benefit in well-defined high-risk cohorts.
- Numerous challenges exist in program implementation, including patient selection, nodule management, and quality assurance.
Conclusions:
- Successful lung cancer screening requires careful program design, addressing identified obstacles.
- Viewing lung cancer screening as a comprehensive program, not merely a test, is crucial for maximizing benefits and minimizing harms.
